{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:35:45Z","timestamp":1788669345367,"version":"build-2803163510"},"reference-count":149,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Human respiratory syncytial virus (HRSV), human metapneumovirus (HMPV), and human parainfluenza viruses (HPIVs) are leading causes of respiratory disease in young children, the elderly, and individuals of all ages with immunosuppression. Vaccination strategies against these pneumoviruses and paramyxoviruses are vast in number, yet no licensed vaccines are available. Here, we review development of Sendai virus (SeV), a versatile pediatric vaccine that can (a) serve as a Jennerian vaccine against HPIV1, (b) serve as a recombinant vaccine against HRSV, HPIV2, HPIV3, and HMPV, (c) accommodate foreign genes for viral glycoproteins in multiple intergenic positions, (d) induce durable, mucosal, B-cell, and T-cell immune responses without enhanced immunopathology, (e) protect cotton rats, African green monkeys, and chimpanzees from infection, and (f) be formulated into a vaccine cocktail. Clinical phase I safety trials of SeV have been completed in adults and 3\u20136-year-old children. Clinical testing of SeVRSV, an HRSV fusion (F) glycoprotein gene recombinant, has also been completed in adults. Positive results from these studies, and collaborative efforts with the National Institutes of Health and the Serum Institute of India assist advanced development of SeV-based vaccines. Prospects are now good for vaccine successes in infants and consequent protection against serious viral disease.<\/jats:p>","DOI":"10.3390\/v13061023","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T03:45:29Z","timestamp":1622432729000},"page":"1023","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-3990","authenticated-orcid":false,"given":"Charles J.","family":"Russell","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children\u2019s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Hurwitz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children\u2019s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"ref_1","unstructured":"(2017). Forum of international respiratory societies. The Global Impact of Respiratory Disease, European Respiratory Society. [2nd ed.]. Available online: https:\/\/www.who.int."},{"key":"ref_2","unstructured":"(2021, March 06). Johns Hopkins University and Medicine Coronavirus Resource Center. Available online: https:\/\/coronavirus.jhu.edu."},{"key":"ref_3","unstructured":"(2021, May 01). Influenza 1918 Pandemic, Available online: https:\/\/www.cdc.gov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: A systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Global Seasonal Influenza-associated Mortality Collaborator, N., Estimates of global seasonal influenza-associated respiratory mortality: A modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcv.2011.07.017","article-title":"Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model","volume":"52","author":"Gaunt","year":"2011","journal-title":"J. Clin. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1204630","article-title":"Burden of human metapneumovirus infection in young children","volume":"368","author":"Edwards","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncy-tial virus in young children in 2015: A systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"ref_9","unstructured":"(2021, March 03). Respiratory Syncytial Virus (RSV), Available online: https:\/\/www.niaid.nih.gov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1016\/S2214-109X(17)30344-3","article-title":"Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): A retrospective case series","volume":"5","author":"Scheltema","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1542\/peds.2014-2151","article-title":"Respiratory syncytial virus-associated mortality in hospitalized infants and young children","volume":"135","author":"Byington","year":"2015","journal-title":"Pediatrics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0036-1584798","article-title":"Parainfluenza Virus Infection","volume":"37","author":"Branche","year":"2016","journal-title":"Semin. Respir. Crit Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1086\/652782","article-title":"Population-based incidence of human metapneumovirus infection among hospitalized children","volume":"201","author":"Williams","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.00010-16","article-title":"Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment","volume":"30","author":"Griffiths","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_17","first-page":"463","article-title":"Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group","volume":"95","author":"Groothuis","year":"1995","journal-title":"Pediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/cpdd.883","article-title":"A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy Adults","volume":"10","author":"Aliprantis","year":"2020","journal-title":"Clin. Pharm. Drug Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/INF.0000000000001533","article-title":"Effectiveness of Palivizumab in High-risk Infants and Children: A Propensity Score Weighted Regression Analysis","volume":"36","author":"Anderson","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Nirsevimab Study, G., Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","article-title":"Taxonomy of the order Mononegavirales: Update 2016","volume":"161","author":"Afonso","year":"2016","journal-title":"Arch Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00705-017-3311-7","article-title":"Taxonomy of the order Mononegavirales: Update 2017","volume":"162","author":"Amarasinghe","year":"2017","journal-title":"Arch Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.vaccine.2014.03.049","article-title":"A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5)","volume":"32","author":"Phan","year":"2014","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e00066-17","DOI":"10.1128\/JVI.00066-17","article-title":"A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"ref_25","first-page":"1449","article-title":"Paramyxoviridae: The viruses and their replication","volume":"Volume 1","author":"Knipe","year":"2007","journal-title":"Fields Virology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0042-6822(02)00016-8","article-title":"Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy","volume":"306","author":"Jeffree","year":"2003","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/jvi.69.4.2667-2673.1995","article-title":"Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells","volume":"69","author":"Roberts","year":"1995","journal-title":"J. Virol."},{"key":"ref_28","first-page":"95","article-title":"Reproduction of paramyxoviruses","volume":"Volume 4","author":"Wagner","year":"1975","journal-title":"Comprehensive Virology, Fraenkel-Conrat, H."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0042-6822(76)90199-9","article-title":"The synthesis of sendai virus polypeptides in infected cells","volume":"69","author":"Lamb","year":"1976","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tim.2006.04.004","article-title":"The structural basis of paramyxovirus invasion","volume":"14","author":"Russell","year":"2006","journal-title":"Trends Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1083\/jcb.200305130","article-title":"A dual-functional paramyxovirus F protein regulatory switch segment: Activation and membrane fusion","volume":"163","author":"Russell","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/emboj\/20.15.4024","article-title":"Membrane fusion machines of paramyxoviruses: Capture of intermediates of fusion","volume":"20","author":"Russell","year":"2001","journal-title":"EMBO J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1128\/JVI.73.11.9237-9246.1999","article-title":"Sendai virus gene start signals are not equivalent in reinitiation capacity: Moderation at the fusion protein gene","volume":"73","author":"Kato","year":"1999","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1099\/0022-1317-78-11-2813","article-title":"Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3\u2019 proximal first locus","volume":"78 Pt 11","author":"Hasan","year":"1997","journal-title":"J. Gen. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-1702(02)00047-3","article-title":"Recombinant Sendai viruses expressing different levels of a foreign reporter gene","volume":"86","author":"Tokusumi","year":"2002","journal-title":"Virus Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1128\/JVI.79.5.2988-2997.2005","article-title":"Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus","volume":"79","author":"Schmitt","year":"2005","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/JVI.76.8.3952-3964.2002","article-title":"Requirements for budding of paramyxovirus simian virus 5 virus-like particles","volume":"76","author":"Schmitt","year":"2002","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11384","DOI":"10.1128\/JVI.75.23.11384-11391.2001","article-title":"Role of matrix and fusion proteins in budding of Sendai virus","volume":"75","author":"Takimoto","year":"2001","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/viro.2000.0291","article-title":"Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: Different role for the two proteins in the production of virus particle","volume":"270","author":"Roux","year":"2000","journal-title":"Virology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sbi.2007.08.016","article-title":"Structural basis of viral invasion: Lessons from paramyxovirus F","volume":"17","author":"Lamb","year":"2007","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nature04322","article-title":"Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation","volume":"439","author":"Yin","year":"2006","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nsmb.2250","article-title":"Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site","volume":"19","author":"Wen","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41467-017-01708-9","article-title":"Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein","volume":"8","author":"Battles","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1073\/pnas.1523303113","article-title":"Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form","volume":"113","author":"Wong","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1073\/pnas.0503989102","article-title":"Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein","volume":"102","author":"Yin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/viro.2000.0267","article-title":"Fusion protein of the paramyxovirus SV5: Destabilizing and stabilizing mutants of fusion activation","volume":"270","author":"Paterson","year":"2000","journal-title":"Virology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.virol.2015.02.037","article-title":"Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry","volume":"479","author":"Bose","year":"2015","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1097-2765(00)80458-X","article-title":"Structural basis for paramyxovirus-mediated membrane fusion","volume":"3","author":"Baker","year":"1999","journal-title":"Mol. Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"13727","DOI":"10.1128\/JVI.78.24.13727-13742.2004","article-title":"Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state","volume":"78","author":"Russell","year":"2004","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.virol.2010.03.050","article-title":"Structure of the Newcastle disease virus F protein in the post-fusion conformation","volume":"402","author":"Swanson","year":"2010","journal-title":"Virology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0969-2126(01)00581-0","article-title":"The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion","volume":"9","author":"Chen","year":"2001","journal-title":"Structure"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.1106536108","article-title":"Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers","volume":"108","author":"Swanson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/81002","article-title":"Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase","volume":"7","author":"Crennell","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yuan, P., Paterson, R.G., Leser, G.P., Lamb, R.A., and Jardetzky, T.S. (2012). Structure of the ulster strain newcastle disease virus hemagglutinin-neuraminidase reveals auto-inhibitory interactions associated with low virulence. PLoS Pathog., 8.","DOI":"10.2210\/pdb4fzh\/pdb"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"14920","DOI":"10.1073\/pnas.1111691108","article-title":"Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk","volume":"108","author":"Yuan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jmb.2003.11.032","article-title":"Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III","volume":"335","author":"Lawrence","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nsmb1342","article-title":"Structure of the measles virus hemagglutinin","volume":"14","author":"Colf","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"19535","DOI":"10.1073\/pnas.0707830104","article-title":"Crystal structure of measles virus hemagglutinin provides insight into effective vaccines","volume":"104","author":"Hashiguchi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nsmb.1969","article-title":"Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM","volume":"18","author":"Hashiguchi","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.str.2005.02.019","article-title":"Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose","volume":"13","author":"Yuan","year":"2005","journal-title":"Structure"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.1073\/pnas.0804797105","article-title":"Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3","volume":"105","author":"Xu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nsmb.1435","article-title":"Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2","volume":"15","author":"Bowden","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1128\/JVI.00317-10","article-title":"Dimeric architecture of the Hendra virus attachment glycoprotein: Evidence for a conserved mode of assembly","volume":"84","author":"Bowden","year":"2010","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Fedechkin, S.O., George, N.L., Wolff, J.T., Kauvar, L.M., and DuBois, R.M. (2018). Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies. Sci. Immunol., 3.","DOI":"10.1126\/sciimmunol.aar3534"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e01879-19","DOI":"10.1128\/JVI.01879-19","article-title":"Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes","volume":"94","author":"Fedechkin","year":"2020","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/jcm.26.8.1595-1597.1988","article-title":"Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity","volume":"26","author":"Murphy","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/jcm.24.2.197-202.1986","article-title":"Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine","volume":"24","author":"Murphy","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Biagi, C., Dondi, A., Scarpini, S., Rocca, A., Vandini, S., Poletti, G., and Lanari, M. (2020). Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines. Vaccines, 8.","DOI":"10.3390\/vaccines8040672"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14745\/ccdr.v46i04a01","article-title":"Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada","volume":"46","author":"Killikelly","year":"2020","journal-title":"Can. Commun. Dis. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Kim, Y.I., DeVincenzo, J.P., Jones, B.G., Rudraraju, R., Harrison, L., Meyers, R., Cehelsky, J., Alvarez, R., and Hurwitz, J.L. (2014). Respiratory syncytial virus human experimental infection model: Provenance, production, and sequence of low-passaged memphis-37 challenge virus. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113100"},{"key":"ref_74","unstructured":"(2021, May 01). RSV Clinical Trial Tracker. Available online: https:\/\/www.path.org\/resources\/rsv-and-mab-trial-tracker."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.virusres.2012.06.027","article-title":"Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248\/404\/1030DeltaSH) at permissive and non-permissive temperatures","volume":"169","author":"Schickli","year":"2012","journal-title":"Virus Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1128\/JVI.01688-08","article-title":"An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats","volume":"82","author":"Mok","year":"2008","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1128\/JVI.77.2.1141-1148.2003","article-title":"Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic","volume":"77","author":"Skiadopoulos","year":"2003","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/j.vaccine.2011.12.022","article-title":"Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children","volume":"30","author":"Karron","year":"2012","journal-title":"Vaccine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"A proof of concept for structure-based vaccine design targeting RSV in humans","volume":"365","author":"Crank","year":"2019","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1128\/JVI.02018-15","article-title":"Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells","volume":"89","author":"Kim","year":"2015","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants","volume":"383","author":"Madhi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination","volume":"384","author":"Widge","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_84","first-page":"217","article-title":"Newborn virus pneumonitis (type Sendai). II. The isolation of a new virus possessing hemagglutinin activity","volume":"4","author":"Kuroya","year":"1953","journal-title":"Yokohama Med. Bull."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7883\/yoken1952.7.345","article-title":"A pneumotropic virus from mice causing hemagglutination","volume":"7","author":"Fukumi","year":"1954","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-3527(08)60103-7","article-title":"Sendai virus","volume":"23","author":"Ishida","year":"1978","journal-title":"Adv. Virus Res."},{"key":"ref_87","unstructured":"Knipe, D.M., Howley, P.M., Griffin, D.E., Martin, M.A., Lamb, R.A., Roizman, B., and Straus, S.E. (2007). Parainfluenza viruses. Fields Virology, Lippincott Williams and Wilkins. [5th ed.]."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/oxfordjournals.aje.a112031","article-title":"An epizootic of Sendai infection with mortality in a barrier-maintained mouse colony","volume":"100","author":"Bhatt","year":"1974","journal-title":"Am. J. Epidemiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1126\/science.146.3646.936","article-title":"Enzootic Sendai Virus Infections in Mouse Breeder Colonies within the United States","volume":"146","author":"Parker","year":"1964","journal-title":"Science"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/oxfordjournals.aje.a120944","article-title":"Enzootic sendai infection in laboratory hamsters","volume":"89","author":"Profeta","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"L777","DOI":"10.1152\/ajplung.00240.2005","article-title":"Sendai virus-induced alterations in lung structure\/function correlate with viral loads and reveal a wide resistance\/susceptibility spectrum among mouse strains","volume":"289","author":"Faisca","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Burke, C.W., Bridges, O., Brown, S., Rahija, R., and Russell, C.J. (2013). Mode of parainfluenza virus transmission determines the dynamics of primary infection and protection from reinfection. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003786"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/JVI.03581-14","article-title":"Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: A noninvasive bioluminescence-imaging study","volume":"89","author":"Burke","year":"2015","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Burke, C.W., Mason, J.N., Surman, S.L., Jones, B.G., Dalloneau, E., Hurwitz, J.L., and Russell, C.J. (2011). Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002134"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: Long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0042-6822(90)90201-2","article-title":"The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity","volume":"175","author":"Gorman","year":"1990","journal-title":"Virology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1099\/0022-1317-72-4-983","article-title":"The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants","volume":"72","author":"Lyn","year":"1991","journal-title":"J. Gen. Virol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1016\/j.vaccine.2010.07.068","article-title":"Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1","volume":"28","author":"Sealy","year":"2010","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0264-410X(97)00217-X","article-title":"Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one","volume":"15","author":"Hurwitz","year":"1997","journal-title":"Vaccine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.2002.1416","article-title":"Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees","volume":"297","author":"Skiadopoulos","year":"2002","journal-title":"Virology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.vaccine.2004.01.053","article-title":"Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults","volume":"22","author":"Slobod","year":"2004","journal-title":"Vaccine"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CVI.00618-14","article-title":"Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children","volume":"22","author":"Adderson","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1128\/JVI.78.11.6043-6047.2004","article-title":"Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV","volume":"78","author":"Takimoto","year":"2004","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1016\/j.vaccine.2007.10.038","article-title":"Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B","volume":"25","author":"Zhan","year":"2007","journal-title":"Vaccine"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1016\/j.vaccine.2014.03.088","article-title":"Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model","volume":"32","author":"Jones","year":"2014","journal-title":"Vaccine"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.vaccine.2008.04.022","article-title":"Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections","volume":"26","author":"Zhan","year":"2008","journal-title":"Vaccine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2009.01.041","article-title":"Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV","volume":"27","author":"Jones","year":"2009","journal-title":"Vaccine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.vaccine.2011.11.046","article-title":"Sendai virus-based RSV vaccine protects African green monkeys from RSV infection","volume":"30","author":"Jones","year":"2012","journal-title":"Vaccine"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/intimm\/dxu107","article-title":"Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats","volume":"27","author":"Zhan","year":"2015","journal-title":"Int. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1128\/JVI.00227-13","article-title":"Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines","volume":"87","author":"Mason","year":"2013","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2017.05.021","article-title":"A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge","volume":"509","author":"Russell","year":"2017","journal-title":"Virology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/viro.1994.1135","article-title":"Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells","volume":"199","author":"Dave","year":"1994","journal-title":"Virology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/viro.1994.1665","article-title":"Age-related development of human memory T-helper and B-cell responses toward parainfluenza virus type-1","volume":"205","author":"Smith","year":"1994","journal-title":"Virology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/viro.1995.1448","article-title":"Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection","volume":"212","author":"Sangster","year":"1995","journal-title":"Virology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.virol.2010.12.017","article-title":"Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut","volume":"410","author":"Rudraraju","year":"2011","journal-title":"Virology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/intimm\/dxw035","article-title":"Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners","volume":"28","author":"Sealy","year":"2016","journal-title":"Int. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/intimm\/dxs107","article-title":"Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines","volume":"25","author":"Sealy","year":"2013","journal-title":"Int. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/jvi.68.9.6083-6086.1994","article-title":"Respiratory virus infection of mice provokes a permanent humoral immune response","volume":"68","author":"Hyland","year":"1994","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1002\/j.1460-2075.1995.tb00299.x","article-title":"A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus","volume":"14","author":"Garcin","year":"1995","journal-title":"EMBO J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2443.1996.d01-261.x","article-title":"Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense","volume":"1","author":"Kato","year":"1996","journal-title":"Genes Cells"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1348-0421.1999.tb02448.x","article-title":"Paramyxovirus reverse genetics is coming of age","volume":"43","author":"Nagai","year":"1999","journal-title":"Microbiol. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-5793(99)00960-6","article-title":"Accommodation of foreign genes into the Sendai virus genome: Sizes of inserted genes and viral replication","volume":"456","author":"Sakai","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"Respiratory Syncytial Virus Network, F., The respiratory syncytial virus vaccine landscape: Lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/21645515.2020.1779517","article-title":"Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults","volume":"17","author":"Bernstein","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Russell, C.J., Penkert, R.R., Kim, S., and Hurwitz, J.L. (2020). Human Metapneumovirus: A Largely Unrecognized Threat to Human Health. Pathogens, 9.","DOI":"10.3390\/pathogens9020109"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"15058","DOI":"10.3390\/ijerph121214965","article-title":"Healthy versus Unhealthy Suppliers in Food Desert Neighborhoods: A Network Analysis of Corner Stores\u2019 Food Supplier Networks","volume":"12","author":"Mui","year":"2015","journal-title":"Int. J. Env. Res. Public Health"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cei.12718","article-title":"Retinol binding protein and vitamin D associations with serum antibody isotypes, serum influenza virus-specific neutralizing activities and airway cytokine profiles","volume":"183","author":"Jones","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/v11100907","article-title":"Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination","volume":"11","author":"Patel","year":"2019","journal-title":"Viruses"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"15893","DOI":"10.1038\/srep15893","article-title":"Obesity Leads to Tissue, but not Serum Vitamin A Deficiency","volume":"5","author":"Trasino","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ijo.2017.131","article-title":"Increased risk of influenza among vaccinated adults who are obese","volume":"41","author":"Neidich","year":"2017","journal-title":"Int. J. Obes."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/oby.22929","article-title":"Vitamin A Corrects Tissue Deficits in Diet-Induced Obese Mice and Reduces Influenza Infection After Vaccination and Challenge","volume":"28","author":"Penkert","year":"2020","journal-title":"Obesity"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3389\/fimmu.2019.01576","article-title":"Influences of Vitamin A on Vaccine Immunogenicity and Efficacy","volume":"10","author":"Penkert","year":"2019","journal-title":"Front Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/intimm\/dxv064","article-title":"Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine\/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells","volume":"28","author":"Penkert","year":"2016","journal-title":"Int. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/CVI.00757-13","article-title":"Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host","volume":"21","author":"Surman","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.vaccine.2014.03.025","article-title":"Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice","volume":"32","author":"Surman","year":"2014","journal-title":"Vaccine"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/infdis\/167.5.1003","article-title":"Vitamin A, infectious disease, and childhood mortality: A 2 cent solution?","volume":"167","author":"Sommer","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_140","first-page":"794","article-title":"Signaling cross-talk between peroxisome proliferator-activated receptor\/retinoid X receptor and estrogen receptor through estrogen response elements","volume":"9","author":"Keller","year":"1995","journal-title":"Mol. Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"20637","DOI":"10.1074\/jbc.M111.227082","article-title":"Cross-talk between the androgen receptor and the liver X receptor: Implications for cholesterol homeostasis","volume":"286","author":"Krycer","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear Receptors, RXR, and the Big Bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/vim.2019.0144","article-title":"From Influenza Virus Infections to Lupus: Synchronous Estrogen Receptor alpha and RNA Polymerase II Binding within the Immunoglobulin Heavy Chain Locus","volume":"33","author":"Jones","year":"2020","journal-title":"Viral Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/intimm\/dxy074","article-title":"Complex sex-biased antibody responses: Estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers","volume":"31","author":"Jones","year":"2019","journal-title":"Int. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Sealy, R.E., Jones, B.G., Surman, S.L., Penkert, R.R., Pelletier, S., Neale, G., and Hurwitz, J.L. (2019). Will Attention by Vaccine Developers to the Host\u2019s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?. Vaccines, 7.","DOI":"10.3390\/vaccines7010026"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Surman, S.L., Penkert, R.R., Sealy, R.E., Jones, B.G., Marion, T.N., Vogel, P., and Hurwitz, J.L. (2020). Consequences of Vitamin A Deficiency: Immunoglobulin Dysregulation, Squamous Cell Metaplasia, Infectious Disease, and Death. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155570"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e00554-20","DOI":"10.1128\/mBio.00554-20","article-title":"Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection","volume":"11","author":"Li","year":"2020","journal-title":"mBio"},{"key":"ref_148","first-page":"12","article-title":"A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike","volume":"118","author":"Lu","year":"2021","journal-title":"Proc. Natl Acad Sci USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/infdis\/jiz202","article-title":"Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates","volume":"220","author":"Rossi","year":"2019","journal-title":"J. Infect. Dis"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/6\/1023\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:10:20Z","timestamp":1760163020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/6\/1023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":149,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["v13061023"],"URL":"https:\/\/doi.org\/10.3390\/v13061023","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]}}}